e-learning
resources
Virtual 2020
Pre-Congress Content
Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diffuse Alveolar Hemorrhage: a life-threatening adverse effect of vaping
D. Ambrozej (Warsaw, Poland), T. Bielecka (Warsaw, Poland), W. Feleszko (Warsaw, Poland), K. Krenke (Warsaw, Poland)
Source:
Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Session:
Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Session type:
E-poster session
Number:
1871
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Ambrozej (Warsaw, Poland), T. Bielecka (Warsaw, Poland), W. Feleszko (Warsaw, Poland), K. Krenke (Warsaw, Poland). Diffuse Alveolar Hemorrhage: a life-threatening adverse effect of vaping. 1871
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Diffuse alveolar hemorrhage: how relevant is etiology?
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Diffuse alveolar haemorrhage
Source: Eur Respir Monogr 2019; 86: 173-187
Year: 2019
Diffuse alveolar haemorrhage and pneumomediastinum after hypoglycaemic seizure
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013
Unusual cause of pulmonary haemorrhage in adolescent
Source: Annual Congress 2013 –Paediatric bronchology
Year: 2013
Late Breaking Abstract - Increased risk of pulmonary embolism in patients with radiological severe COVID-19 pneumonia
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020
Broncholithiasis as a cause of pulmonary hemorrhages
Source: Eur Respir J 2007; 30: Suppl. 51, 543s
Year: 2007
Alveolar hemorrhage syndrome in children
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Hemorrhagic complications of treatment in patients with pulmonary embolism
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Uncommon pulmonary complications of inhaled cannabinoide
Source: Eur Respir J 2004; 24: Suppl. 48, 537s
Year: 2004
Clinical features and outcomes of patients with diffuse alveolar hemorrhage during antithrombotic therapy
Source: International Congress 2014 – ILDs 5
Year: 2014
Severe pulmonara hemorrhage
Source: International Congress 2019 – CCC Airway diseases
Year: 2019
Pulmonary emboli: a rare cause of acute chest syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 47s
Year: 2006
Effectiveness of corticosteroid in diffuse alveolar hemorrhage with hematologic malignancy
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Pulmonary vasculitis presenting as acute diffuse alveolar haemorrhage (DAH)
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018
Management of spontaneous pneumothorax in patients with or without Birt-Hogg-Dubé syndrome
Source: International Congress 2014 – ILDs 1
Year: 2014
Amphetamine induced eosinophilic pneumonia: A case report
Source: International Congress 2014 – ILDs 6
Year: 2014
Diffuse alveolar hemorrhage dominant in right lung is due to cardiac comorbidity
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Pulmonary siderosis as a cause of systemic iron overload
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015
Isolated anthracosis: A benign but little-known cause of bronchial stenosis and obstruction
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013
Fibrosing mediastinitis as a rare mechanism of pulmonary oedema in sarcoidosis
Source: Eur Respir J 2010; 35: 455-456
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept